Busy professionals make up about half of our mini myers iv clients
Peng a sports-medicine physician summarizes from his own patients: promising but unproven the biology makes sense, the early safety data is encouraging, but we need large, well-designed human trials. TB-500 is not FDA/Health Canada approved and is also banned in sport
Semaglutide 2.4 mg (Wegovy): ~15% body weight loss at 68 weeks in clinical trials Tirzepatide 15 mg (Zepbound): ~21% body weight loss at 72 weeks in clinical trials Real-world data shows lower results: Cleveland Clinic research from 2025 found average weight loss of 7.7% with semaglutide and 12.4% with tirzepatide at one year in routine clinical practice
Advanced Thyroid Cancer: State of the Art Management
doi: 10.1021/acsomega.9b00974
Additionally, participants were advised to follow a Mediterranean diet , engage in regular physical activity, avoid smoking, and limit alcohol intake making it difficult to attribute results to the supplement itself